C07C 53/40
Acetyl halides
C07C53/40 (Acetyl halides) appears on 8 US grants and 8 published applications in this corpus.
Search patents in C07C- Granted patents
- 8
- Published applications
- 8
- Assignees
- 5
- Inventors
- 11
- Latest grant
- 10 Sep 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 2 |
| 2016 | 2 | 2 |
| 2017 | 2 | 1 |
| 2018 | 1 | 2 |
| 2019 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- 5-HT3 receptor antagonists10 Sep 2019US 10,407,443 B2Takeda Pharmaceutical Company Limited
- 5-HT3 receptor antagonists13 Nov 2018US 10,125,145 B2Takeda Pharmaceutical Company Limited
- 5-HT3 receptor antagonists4 Jul 2017US 9,695,195 B2Takeda Pharmaceutical Company Limited
- 5-HT3 receptor antagonists6 Jun 2017US 9,670,229 B2Takeda Pharmaceutical Company Limited
- 5-HT3 receptor antagonists24 May 2016US 9,346,829 B2Takeda Phamaceutical Company Limited
- 5-ht3 receptor antagonists15 Nov 2018US 2018/0327421 A1Takeda Pharmaceutical Company Limited
- 5ht3 receptor antagonists15 Mar 2018US 2018/0072758 A1Takeda Pharmaceutical Company Limited
- 5-ht3 receptor antagonists14 Sep 2017US 2017/0260201 A1Takeda Pharmaceutical Company Limited
- 5-ht3 receptor antagonists1 Sep 2016US 2016/0251373 A1Takeda Pharmaceutical Company Limited
- 5-ht3 receptor antagonists30 Jun 2016US 2016/0185801 A1Takeda Pharmaceutical Company Limited
Most cited
By later US patents
- Oxygenated alkyl substituted bicyclo alkanes7US 4,689,345 ACBD Corporation · 1987
- 5-HT3 receptor antagonists7US 9,012,447 B2Takeda Pharmaceutical Company Limited · 2015
- 5-HT3 receptor antagonists4US 9,303,045 B2Takeda Pharmaceutical Company Limited · 2016
- 5-HT3 receptor antagonists4US 9,346,829 B2Takeda Phamaceutical Company Limited · 2016
- 5-HT3 receptor antagonists3US 9,670,229 B2Takeda Pharmaceutical Company Limited · 2017